Cargando…
Immunotherapy approaches for the treatment of diffuse midline gliomas
Diffuse midline gliomas (DMG) are a highly aggressive and universally fatal subgroup of pediatric tumors responsible for the majority of childhood brain tumor deaths. Median overall survival is less than 12 months with a 90% mortality rate at 2 years from diagnosis. Research into the underlying tumo...
Autores principales: | Bernstock, Joshua D., Hoffman, Samantha E., Kappel, Ari D., Valdes, Pablo A., Essayed, Walid Ibn, Klinger, Neil V., Kang, Kyung-Don, Totsch, Stacie K., Olsen, Hannah E., Schlappi, Charles W., Filipski, Katharina, Gessler, Florian A., Baird, Lissa, Filbin, Mariella G., Hashizume, Rintaro, Becher, Oren J., Friedman, Gregory K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519005/ https://www.ncbi.nlm.nih.gov/pubmed/36185807 http://dx.doi.org/10.1080/2162402X.2022.2124058 |
Ejemplares similares
-
Positioning Transclival Tumor-Treating Fields for the Treatment of Diffuse Intrinsic Pontine Gliomas
por: Ibn Essayed, Walid, et al.
Publicado: (2023) -
Standard clinical approaches and emerging modalities for glioblastoma imaging
por: Bernstock, Joshua D, et al.
Publicado: (2022) -
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
por: Dhar, Swati, et al.
Publicado: (2022) -
DIPG-39. New preclinical models for Diffuse Midline Glioma
por: Klenner, Marbod, et al.
Publicado: (2022) -
ET-03 Convection-enhanced delivery of EZH2 inhibitor for the treatment of diffuse midline glioma
por: Sasaki, Takahiro, et al.
Publicado: (2020)